This drug class confers benefits in diabetic patients with heart failure, CV disease, and renal disease, but it is also associated with major adverse events.
Although there is no cure for gastroparesis, changes to the diet, along with a variety of recent and longstanding medications, can offer some relief of symptoms.
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.